Literature DB >> 31385762

Antiviral Activities of Human Host Defense Peptides.

David C Brice1, Gill Diamond1.   

Abstract

Peptides with broad-spectrum antimicrobial activity are found widely expressed throughout nature. As they participate in a number of different aspects of innate immunity in mammals, they have been termed Host Defense Peptides (HDPs). Due to their common structural features, including an amphipathic structure and cationic charge, they have been widely shown to interact with and disrupt microbial membranes. Thus, it is not surprising that human HDPs have activity against enveloped viruses as well as bacteria and fungi. However, these peptides also exhibit activity against a wide range of non-enveloped viruses as well, acting at a number of different steps in viral infection. This review focuses on the activity of human host defense peptides, including alpha- and beta-defensins and the sole human cathelicidin, LL-37, against both enveloped and non-enveloped viruses. The broad spectrum of antiviral activity of these peptides, both in vitro and in vivo suggest that they play an important role in the innate antiviral defense against viral infections. Furthermore, the literature suggests that they may be developed into antiviral therapeutic agents. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Antimicrobial peptide; LL-37; defensin; host defense peptide; innate immunity; virus.

Mesh:

Substances:

Year:  2020        PMID: 31385762      PMCID: PMC9008596          DOI: 10.2174/0929867326666190805151654

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  201 in total

1.  Oral human β-defensin 2 in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  Wipawee Nittayananta; Marisa Kemapunmanus; Korntip Amornthatree; Sineepat Talungchit; Hutcha Sriplung
Journal:  J Oral Pathol Med       Date:  2012-06-09       Impact factor: 4.253

Review 2.  The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.

Authors:  Myron S Cohen; Nick Hellmann; Jay A Levy; Kevin DeCock; Joep Lange
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 3.  Antimicrobial Peptides as a Strategy to Combat Fungal Biofilms.

Authors:  Nicolas Delattin; Katrijn De Brucker; Kaat De Cremer; Bruno P A Cammue; Karin Thevissen
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

4.  Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro.

Authors:  A Bastian; H Schäfer
Journal:  Regul Pept       Date:  2001-09-15

5.  Isolation and transmission of human retrovirus (human t-cell leukemia virus).

Authors:  M Popovic; P S Sarin; M Robert-Gurroff; V S Kalyanaraman; D Mann; J Minowada; R C Gallo
Journal:  Science       Date:  1983-02-18       Impact factor: 47.728

6.  Human beta-defensin 1, 2 and 3 production by amniotic epithelial cells with respect to human papillomavirus (HPV) infection, HPV oncogenic potential and the mode of delivery.

Authors:  Dariusz Szukiewicz; Habib Alkhalayla; Michal Pyzlak; Mateusz Watroba; Grzegorz Szewczyk; Jaroslaw Wejman
Journal:  Microb Pathog       Date:  2016-06-08       Impact factor: 3.738

7.  Activity of alpha- and theta-defensins against primary isolates of HIV-1.

Authors:  Wei Wang; Sherry M Owen; Donna L Rudolph; Alexander M Cole; Teresa Hong; Alan J Waring; Renu B Lal; Robert I Lehrer
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

8.  Antiviral activity of human beta-defensin 3 against vaccinia virus.

Authors:  Michael D Howell; Joanne E Streib; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2007-03-13       Impact factor: 10.793

9.  Single, double and quadruple alanine substitutions at oligomeric interfaces identify hydrophobicity as the key determinant of human neutrophil alpha defensin HNP1 function.

Authors:  Le Zhao; W David Tolbert; Bryan Ericksen; Changyou Zhan; Xueji Wu; Weirong Yuan; Xu Li; Marzena Pazgier; Wuyuan Lu
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

10.  Cathelicidins display conserved direct antiviral activity towards rhinovirus.

Authors:  Filipa Henderson Sousa; Victor Casanova; Fern Findlay; Craig Stevens; Pavel Svoboda; Jan Pohl; Lorna Proudfoot; Peter G Barlow
Journal:  Peptides       Date:  2017-07-29       Impact factor: 3.750

View more
  26 in total

1.  Broad-spectrum Respiratory Virus Entry Inhibitors.

Authors:  Hanjun Zhao; Kwok-Yung Yuen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Bomidin: An Optimized Antimicrobial Peptide With Broad Antiviral Activity Against Enveloped Viruses.

Authors:  Rongrong Liu; Ziyu Liu; Haoran Peng; Yunhua Lv; Yunan Feng; Junjun Kang; Naining Lu; Ruixue Ma; Shiyuan Hou; Wenjie Sun; Qikang Ying; Fang Wang; Qikang Gao; Ping Zhao; Cheng Zhu; Yixing Wang; Xingan Wu
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

3.  VP4 Is a Determinant of Alpha-Defensin Modulation of Rotaviral Infection.

Authors:  Ciara T Hu; Karina Diaz; Linda C Yang; Anjali Sharma; Harry B Greenberg; Jason G Smith
Journal:  J Virol       Date:  2022-03-14       Impact factor: 6.549

Review 4.  Anti-Microbial Peptides: Strategies of Design and Development and Their Promising Wound-Healing Activities.

Authors:  Fariba Fathi; Maryam Ghobeh; Maryam Tabarzad
Journal:  Mol Biol Rep       Date:  2022-05-08       Impact factor: 2.742

5.  Type I interferon and interferon-stimulated gene expression in oral epithelial cells.

Authors:  D C Brice; E Figgins; F Yu; G Diamond
Journal:  Mol Oral Microbiol       Date:  2019-10-21       Impact factor: 3.563

Review 6.  Expression and Roles of Antimicrobial Peptides in Innate Defense of Airway Mucosa: Potential Implication in Cystic Fibrosis.

Authors:  Regina Geitani; Carole Ayoub Moubareck; Zhengzhong Xu; Dolla Karam Sarkis; Lhousseine Touqui
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

Review 7.  Strategies in Translating the Therapeutic Potentials of Host Defense Peptides.

Authors:  Darren Shu Jeng Ting; Roger W Beuerman; Harminder S Dua; Rajamani Lakshminarayanan; Imran Mohammed
Journal:  Front Immunol       Date:  2020-05-22       Impact factor: 7.561

8.  Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.

Authors:  James J DiNicolantonio; Jorge Barroso-Aranda
Journal:  Med Hypotheses       Date:  2020-07-02       Impact factor: 1.538

9.  Network Medicine Approach for Analysis of Alzheimer's Disease Gene Expression Data.

Authors:  David Cohen; Alexander Pilozzi; Xudong Huang
Journal:  Int J Mol Sci       Date:  2020-01-03       Impact factor: 5.923

10.  Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.

Authors:  R Pal; M Banerjee; S K Bhadada; A J Shetty; B Singh; A Vyas
Journal:  J Endocrinol Invest       Date:  2021-06-24       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.